Carillon Tower Advisers, an investment management company, released the “Carillon Clarifest Capital Appreciation Fund” in the second quarter 2022 investor letter. A copy of it can be downloaded here. Global equities markets faced significant declines in the first half of 2022 due to concerns such as the Russia/Ukraine war, rising inflation, COVID-19, and central-bank tightening. At the end of the second quarter, the portfolio was most underweight in the consumer discretionary and industrial sectors and most overweight in the information technology and healthcare sectors. But all sectors in the Russell 1000 Index are negative. However, stock selection and sector allocation contributed positively to the fund’s performance. In addition, you can review the fund’s top 5 holdings to find out its best picks in 2022.
Carillon Tower Advisers discussed stocks like Pfizer Inc. (NYSE:PFE) in the second quarter 2022 investor letter. Headquartered in New York, New York, Pfizer Inc. (NYSE:PFE) is a biopharmaceutical company. On October 5, 2022, Pfizer Inc. stock closed (NYSE:PFE) at $44.12 per share. The one-month return of Pfizer Inc. (NYSE:PFE) is -4.36% and its shares have gained 5.00% of their value over the past 52 weeks. Pfizer Inc. (NYSE:PFE) has a market capitalization of $247.617 billion.
Here’s what Carillon Tower Advisers specifically said about Pfizer Inc. (NYSE:PFE) in its Q2 2022 investor letter:
“Pfizer Inc. (NYSE:PFE) is a research-based global biopharmaceutical company. The United States has agreed to pay Pfizer and its vaccine partner more than $3 billion in a deal for their messenger RNA shots against COVID-19. Additionally, the US Food and Drug Administration has approved the company’s COVID vaccine for children ages 5 to 11.
Photo by Spencer Davis on Unsplash
Pfizer Inc. (NYSE:PFE) was not on our list of the 30 Most Popular Stocks in Hedge Funds. According to our database, 70 hedge fund portfolios hold Pfizer Inc. (NYSE:PFE) at the end of the second quarter which was 79 last quarter.
We discussed Pfizer Inc. (NYSE:PFE) in another article and we shared the list of COVID stocks to invest. In addition, please see our hedge fund investor letter Q2 2022 page for more investor letters from hedge funds and other leading investors.
Suggested Articles:
Disclosure: None. This article was originally published on Insider Monkey.